Chromatin-derived acidic peptides modulate catecholamine release in the hypothalamus

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Acidic peptides (ACPs) are derived from chromatin.
• Synthetic analogs of ACPs were designed to study their biological activity.
• Eukaryotic RNA polymerase II C-terminal fragment is a source for ACP analogs.

Purpose of the Study:

• To investigate the neuromodulatory effects of three synthetic peptides (ACP-1, ACP-2, ACP-3) on neurotransmitter release.
• To determine the influence of lipophilicity and phosphorylation on peptide activity.
• To assess the impact of these peptides on dopamine and norepinephrine release in rat hypothalamic synaptosomes.

Main Methods:

• Preparation of rat hypothalamic synaptosomes.
• Loading synaptosomes with [(3)H]norepinephrine or [(3)H]dopamine.
• Perfusion of synaptosomes with synthetic peptides (ACP-1, ACP-2, ACP-3) under basal and depolarizing conditions.
• Measurement of neurotransmitter release.

Main Results:

• ACP-1 significantly inhibited the release of both dopamine and norepinephrine.
• ACP-2 demonstrated selective inhibition of dopamine release, with no effect on norepinephrine release.
• ACP-3 showed minimal activity, with only a weak inhibition of dopamine release observed at higher concentrations.

Conclusions:

• Synthetic peptides structurally related to acidic peptides (ACPs) exhibit neuromodulatory effects on monoamine release.
• Lipophilicity and phosphorylation influence the specificity and potency of ACP analogs.
• These findings suggest potential roles for ACPs or their derivatives in regulating neurotransmission.